IQVIA Report Predicts the "Next Large Wave of Biosimilars"
The IQVIA Institute for Human Data Science (formerly the IMS institute) has released a new report making predictions for the healthcare landscape in 2018 and beyond, and the report’s authors see biosimilars as having a key role in developed markets in the years ahead.
IQVIA predicts that, in 2018, $19 billion of current spending on biologics will become exposed to competition from biosimilars for the first time, in 1 or more developed markets. Compared to $3 billion that be